PT-141, also known as bremelanotide, is a synthetic melanocortin receptor agonist developed for laboratory research. It is used to study neuroendocrine signaling and behavioral responses in experimental models.
PT-141
$60.00
In stock
Frequently Bought Together
Frequently Bought Together
PT-141, or bremelanotide, is a synthetic peptide designed as a melanocortin receptor agonist for in vitro and animal model research to investigate neuroendocrine signaling pathways and behavioral responses. It is utilized in laboratory studies to explore its interactions with melanocortin receptors, particularly MC3R and MC4R, focusing on their roles in modulating neural pathways in cell lines and rodent models under controlled conditions. Researchers employ PT-141 to assess its binding affinity, stability, and effects on signal transduction, often using analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry to confirm its structural integrity and purity. This peptide is intended exclusively for scientific investigations to deepen understanding of melanocortin-mediated mechanisms in experimental research settings.
| Size | 10mg |
|---|
Product Use & Compliance Notice
Not for human consumption and intended for research purposes only. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Crescent Chems Research is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act.
